Patient P-01302
Synthetic patientNBL-101 · Day 116 · 35–44 · M · baseline S11Steering view · 3DOpen companion preview
Therapy response
Improving
Tolerance
Deteriorating
GI state
Deteriorating
Inflammatory state
Deteriorating
Nutritional resilience
Declining
Discontinuation risk
29%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 NBL-101 started — Baseline state S11
- Day 54 SC-12 recommended — Supportive Compound SC-12
- Day 55 Patient accepted — Started SC-12 in the companion
- Day 61 No meaningful change — Supportive Compound SC-12
What changed?
Trajectory is tracking the baseline prediction.
Primary contributors, last 14 days
- GI instability+10
- Nutritional resilience-8
- Toxicity+6
- Inflammatory activity+4
- Treatment adherence+2
What helped?
- Supportive Compound SC-12Day 54Result: no meaningful change
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
GI burden
Companion20.5/100
worsening · +5.8 vs previous 14 d
Toxicity
Blood23.4/100
worsening · +7.3 vs previous 14 d
Sleep quality
Wearable49.6/100
worsening · -3.2 vs previous 14 d
Energy level
Daily log5.7/10
worsening · -0.8 vs previous 14 d
Stress level
Daily log5.3/10
worsening · +0.5 vs previous 14 d
Steps
Wearable7,674
worsening · -426 vs previous 14 d
Adherence
Companion89.5 %
stable · -0.9 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards restoration · 94 from the failing basin, 17 from restoration.
Would help
- No untried action with strong evidence. Compose one from primitives.
Would not help
- SC-12 Supportive Compoundalready tried, no meaningful change
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Spicy / capsaicin-1.8no signal · 40%
- Histamine load+1.3no signal · 24%
- Alcohol+1.1no signal · 24%
- Simple carbohydrates-0.9no signal · 19%
- Insoluble fibre-0.9no signal · 18%
- Dietary fat load+0.8no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Inflammatory signalling ↑20
- MicrobiomeBacteroides fragilis expansion
DNA
Fictional pharmacogenomic panel
- CYP2D6 Intermediate metabolizerExpected exposure
- MTHFR C677TReduced folate turnover
Microbiome
Shannon diversity 3.2 · butyrate capacity 58/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisHigh
- Bifidobacterium longumLow
- EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 39 ms
- Sleep
- 6.7 h
- Steps
- 8,369
- Resting HR
- 71 bpm
Daily log: GI score 21, nutritional resilience 62, adherence 90.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Keep fibre steady; no new sources this week
- Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the scheduled dose as agreed with your care team
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.